Moderna (MRNA) is in talks with at least one large drugmaker on a deal of significant scope, including a buyout, a person familiar with the discussions told STAT News. Though the precise nature of the potential agreement was unclear, a buyout is on the table, Jason Mast reported after having interviewed more than two dozen former and current Moderna employees, along with analysts, rival executives, investors, and experts in mRNA and vaccines.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA: